GOODRX HOLDINGS INC-CLASS A (GDRX) Stock Fundamental Analysis
USA - NASDAQ:GDRX - US38246G1085 - Common Stock
4.19 USD
-0.03 (-0.71%)
4.22 USD
+0.03 (+0.72%)
We assign a fundamental rating of 6 out of 10 to GDRX. GDRX was compared to 35 industry peers in the Health Care Technology industry. Both the profitability and the financial health of GDRX get a neutral evaluation. Nothing too spectacular is happening here. A decent growth rate in combination with a cheap valuation! Better keep an eye on GDRX. This makes GDRX very considerable for value investing!
1. Profitability
1.1 Basic Checks
In the past year GDRX was profitable.
GDRX had a positive operating cash flow in the past year.
GDRX had negative earnings in 4 of the past 5 years.
GDRX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
GDRX has a better Return On Assets (2.62%) than 91.43% of its industry peers.
Looking at the Return On Equity, with a value of 5.38%, GDRX belongs to the top of the industry, outperforming 91.43% of the companies in the same industry.
GDRX's Return On Invested Capital of 5.90% is amongst the best of the industry. GDRX outperforms 88.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.62% | ||
| ROE | 5.38% | ||
| ROIC | 5.9% |
ROA(3y)-0.47%
ROA(5y)-4.59%
ROE(3y)-0.98%
ROE(5y)-9.45%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
GDRX has a better Profit Margin (4.33%) than 88.57% of its industry peers.
GDRX's Profit Margin has declined in the last couple of years.
The Operating Margin of GDRX (11.10%) is better than 91.43% of its industry peers.
In the last couple of years the Operating Margin of GDRX has declined.
Looking at the Gross Margin, with a value of 93.68%, GDRX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of GDRX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.1% | ||
| PM (TTM) | 4.33% | ||
| GM | 93.68% |
OM growth 3Y66.59%
OM growth 5Y-25.41%
PM growth 3YN/A
PM growth 5Y-34.38%
GM growth 3Y0.06%
GM growth 5Y-0.52%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GDRX is destroying value.
Compared to 1 year ago, GDRX has less shares outstanding
The number of shares outstanding for GDRX remains at a similar level compared to 5 years ago.
Compared to 1 year ago, GDRX has an improved debt to assets ratio.
2.2 Solvency
GDRX has an Altman-Z score of 1.01. This is a bad value and indicates that GDRX is not financially healthy and even has some risk of bankruptcy.
GDRX has a Altman-Z score (1.01) which is comparable to the rest of the industry.
GDRX has a debt to FCF ratio of 4.14. This is a neutral value as GDRX would need 4.14 years to pay back of all of its debts.
GDRX's Debt to FCF ratio of 4.14 is in line compared to the rest of the industry. GDRX outperforms 60.00% of its industry peers.
GDRX has a Debt/Equity ratio of 0.75. This is a neutral value indicating GDRX is somewhat dependend on debt financing.
GDRX has a worse Debt to Equity ratio (0.75) than 77.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.75 | ||
| Debt/FCF | 4.14 | ||
| Altman-Z | 1.01 |
ROIC/WACC0.57
WACC10.42%
2.3 Liquidity
A Current Ratio of 4.21 indicates that GDRX has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.21, GDRX belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
GDRX has a Quick Ratio of 4.21. This indicates that GDRX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 4.21, GDRX belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.21 | ||
| Quick Ratio | 4.21 |
3. Growth
3.1 Past
GDRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.67%, which is quite good.
The earnings per share for GDRX have been decreasing by -24.47% on average. This is quite bad
Looking at the last year, GDRX shows a small growth in Revenue. The Revenue has grown by 3.19% in the last year.
Measured over the past years, GDRX shows a quite strong growth in Revenue. The Revenue has been growing by 15.34% on average per year.
EPS 1Y (TTM)16.67%
EPS 3Y0%
EPS 5Y-24.47%
EPS Q2Q%12.5%
Revenue 1Y (TTM)3.19%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%1.23%
3.2 Future
Based on estimates for the next years, GDRX will show a very strong growth in Earnings Per Share. The EPS will grow by 24.30% on average per year.
The Revenue is expected to grow by 5.48% on average over the next years.
EPS Next Y15.74%
EPS Next 2Y18.32%
EPS Next 3Y16.99%
EPS Next 5Y24.3%
Revenue Next Year0.65%
Revenue Next 2Y2.95%
Revenue Next 3Y4.51%
Revenue Next 5Y5.48%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 11.97, the valuation of GDRX can be described as very reasonable.
GDRX's Price/Earnings ratio is rather cheap when compared to the industry. GDRX is cheaper than 100.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.30. GDRX is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 9.07, the valuation of GDRX can be described as reasonable.
GDRX's Price/Forward Earnings ratio is rather cheap when compared to the industry. GDRX is cheaper than 94.29% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of GDRX to the average of the S&P500 Index (22.73), we can say GDRX is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.97 | ||
| Fwd PE | 9.07 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GDRX indicates a rather cheap valuation: GDRX is cheaper than 91.43% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, GDRX is valued cheaply inside the industry as 94.29% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.3 | ||
| EV/EBITDA | 10.09 |
4.3 Compensation for Growth
GDRX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
GDRX has a very decent profitability rating, which may justify a higher PE ratio.
GDRX's earnings are expected to grow with 16.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.76
PEG (5Y)N/A
EPS Next 2Y18.32%
EPS Next 3Y16.99%
5. Dividend
5.1 Amount
No dividends for GDRX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
4.19
-0.03 (-0.71%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners59.43%
Inst Owner Change-2.04%
Ins Owners11.7%
Ins Owner Change4.09%
Market Cap1.46B
Analysts75.45
Price Target5.43 (29.59%)
Short Float %6.54%
Short Ratio1.65
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.93%
Min EPS beat(2)-10.74%
Max EPS beat(2)-7.12%
EPS beat(4)0
Avg EPS beat(4)-8.89%
Min EPS beat(4)-10.74%
Max EPS beat(4)-7.12%
EPS beat(8)3
Avg EPS beat(8)-2.91%
EPS beat(12)7
Avg EPS beat(12)10.94%
EPS beat(16)10
Avg EPS beat(16)12.14%
Revenue beat(2)0
Avg Revenue beat(2)-2.45%
Min Revenue beat(2)-3.3%
Max Revenue beat(2)-1.6%
Revenue beat(4)0
Avg Revenue beat(4)-2.4%
Min Revenue beat(4)-3.3%
Max Revenue beat(4)-1.6%
Revenue beat(8)0
Avg Revenue beat(8)-2.55%
Revenue beat(12)1
Avg Revenue beat(12)-1.8%
Revenue beat(16)2
Avg Revenue beat(16)-1.63%
PT rev (1m)-15.79%
PT rev (3m)-18.95%
EPS NQ rev (1m)-7.02%
EPS NQ rev (3m)-6.07%
EPS NY rev (1m)-3.45%
EPS NY rev (3m)-3.59%
Revenue NQ rev (1m)-4.86%
Revenue NQ rev (3m)-5.4%
Revenue NY rev (1m)-2.57%
Revenue NY rev (3m)-2.63%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.97 | ||
| Fwd PE | 9.07 | ||
| P/S | 1.82 | ||
| P/FCF | 12.3 | ||
| P/OCF | 7.63 | ||
| P/B | 2.26 | ||
| P/tB | 83.38 | ||
| EV/EBITDA | 10.09 |
EPS(TTM)0.35
EY8.35%
EPS(NY)0.46
Fwd EY11.03%
FCF(TTM)0.34
FCFY8.13%
OCF(TTM)0.55
OCFY13.11%
SpS2.3
BVpS1.85
TBVpS0.05
PEG (NY)0.76
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.62% | ||
| ROE | 5.38% | ||
| ROCE | 7.47% | ||
| ROIC | 5.9% | ||
| ROICexc | 7.74% | ||
| ROICexgc | 24.97% | ||
| OM | 11.1% | ||
| PM (TTM) | 4.33% | ||
| GM | 93.68% | ||
| FCFM | 14.8% |
ROA(3y)-0.47%
ROA(5y)-4.59%
ROE(3y)-0.98%
ROE(5y)-9.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y37.95%
ROICexcg growth 5Y-33.14%
ROICexc growth 3Y52.2%
ROICexc growth 5Y-28.33%
OM growth 3Y66.59%
OM growth 5Y-25.41%
PM growth 3YN/A
PM growth 5Y-34.38%
GM growth 3Y0.06%
GM growth 5Y-0.52%
F-Score8
Asset Turnover0.61
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.75 | ||
| Debt/FCF | 4.14 | ||
| Debt/EBITDA | 2.92 | ||
| Cap/Depr | 93.99% | ||
| Cap/Sales | 9.07% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 115.02% | ||
| Profit Quality | 342.04% | ||
| Current Ratio | 4.21 | ||
| Quick Ratio | 4.21 | ||
| Altman-Z | 1.01 |
F-Score8
WACC10.42%
ROIC/WACC0.57
Cap/Depr(3y)84.93%
Cap/Depr(5y)109.87%
Cap/Sales(3y)7.84%
Cap/Sales(5y)6.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.67%
EPS 3Y0%
EPS 5Y-24.47%
EPS Q2Q%12.5%
EPS Next Y15.74%
EPS Next 2Y18.32%
EPS Next 3Y16.99%
EPS Next 5Y24.3%
Revenue 1Y (TTM)3.19%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%1.23%
Revenue Next Year0.65%
Revenue Next 2Y2.95%
Revenue Next 3Y4.51%
Revenue Next 5Y5.48%
EBIT growth 1Y407.89%
EBIT growth 3Y70.01%
EBIT growth 5Y-13.97%
EBIT Next Year37.85%
EBIT Next 3Y17.74%
EBIT Next 5Y12.79%
FCF growth 1Y70.28%
FCF growth 3Y-7.68%
FCF growth 5Y7.91%
OCF growth 1Y49.36%
OCF growth 3Y0.94%
OCF growth 5Y17.16%